"Building on Lilly's legacy of innovation in insulin therapy, once-weekly efsitora may offer a significant advancement for people with type 2 diabetes who need insulin by eliminating over 300 ...
LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Paris:ADOC) (Euronext Paris: FR0011184241 – ADOC, the “Company”), the biopharmaceutical company focused on the treatment of diabetes and other ...
News-Medical.Net on MSN
Smarter insulin pump systems help stabilize glucose in young patients, study reveals
A Polish study comparing insulin pump technologies in children with type 1 diabetes found that advanced hybrid closed-loop ...
There are currently very few studies into the differences in gut microbiomes between races, despite significant differences between black and white individuals' average insulin resistance, BMI, and ...
Efsitora met the primary endpoint in both QWINT-2 and QWINT-4 with once-a-week dosing regimen for people living with type 2 diabetes Efsitora was equally safe and effective among adults naïve to ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/42t2ns/insulin) has announced the addition of the "Insulin Resistance ...
The study also showed daily energy intake was inversely correlated with estimated glucose disposal rate (eGDR), a marker for insulin resistance (IR). Higher intake of fat, but not carbohydrates, is ...
Eric Moyal ’17, IBS MA’18, MS’22 — a 2024 BOLD Rising Star Award recipient — is on a mission to rein in the exorbitant cost of insulin. Currently, more than a million people in the U.S. who rely on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback